Consistency of Immunogenicity and Non Inferiority of GSK Biologicals' Candidate Malaria Vaccine Lots in Children
Clinical trial NCT01323972 · COMPLETED
Trial details
- NCT number
- NCT01323972
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-16
- Primary completion
- 2011-11-22
- Enrollment
- 327
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.